Literature DB >> 24886775

Behavioral analysis of male and female Fmr1 knockout mice on C57BL/6 background.

Qi Ding1, Ferzin Sethna2, Hongbing Wang3.   

Abstract

Fragile X syndrome (FXS) is a monogenic disease caused by mutations in the FMR1 gene. The Fmr1 knockout (KO) mice show many aspects of FXS-related phenotypes, and have been used as a major pre-clinical model for FXS. Although FXS occurs in both male and female patients, most studies on the mouse model use male animals. Few studies test whether gender affects the face validity of the mouse model. Here, we examined multiple behavioral phenotypes with male hemizygous and female homozygous Fmr1 KO mice on C57BL/6 background. For each behavioral paradigm, we examined multiple cohorts from different litters. We found that both male and female Fmr1 KO mice displayed significant audiogenic seizures, hyperactivity in the open field test, deficits in passive avoidance and contextual fear memory, and significant enhancement of PPI at low stimulus intensity. Male and female Fmr1 KO mice also showed more transitional movement between the lit and dark chambers in the light-dark tests. The lack of gender effects suggests that the Fmr1 KO mouse is a reasonable tool to test the efficacy of potential FXS therapies.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Behavioral phenotypes; Fmr1 knockout mice; Fragile X syndrome; Gender; Genetic background

Mesh:

Substances:

Year:  2014        PMID: 24886775      PMCID: PMC4104211          DOI: 10.1016/j.bbr.2014.05.046

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  41 in total

1.  Alterations in the auditory startle response in Fmr1 targeted mutant mouse models of fragile X syndrome.

Authors:  Darci M Nielsen; William J Derber; Danielle A McClellan; Linda S Crnic
Journal:  Brain Res       Date:  2002-02-08       Impact factor: 3.252

Review 2.  Molecular mechanisms of fragile X syndrome: a twenty-year perspective.

Authors:  Michael R Santoro; Steven M Bray; Stephen T Warren
Journal:  Annu Rev Pathol       Date:  2011-10-10       Impact factor: 23.472

3.  Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome.

Authors:  V Brown; P Jin; S Ceman; J C Darnell; W T O'Donnell; S A Tenenbaum; X Jin; Y Feng; K D Wilkinson; J D Keene; R B Darnell; S T Warren
Journal:  Cell       Date:  2001-11-16       Impact factor: 41.582

4.  Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function.

Authors:  W Paradee; H E Melikian; D L Rasmussen; A Kenneson; P J Conn; S T Warren
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

5.  Genetic reduction of muscarinic M4 receptor modulates analgesic response and acoustic startle response in a mouse model of fragile X syndrome (FXS).

Authors:  Surabi Veeraragavan; Deanna Graham; Nghiem Bui; Lisa A Yuva-Paylor; Jürgen Wess; Richard Paylor
Journal:  Behav Brain Res       Date:  2011-11-23       Impact factor: 3.332

6.  Fmr1 knockout mouse has a distinctive strain-specific learning impairment.

Authors:  C Dobkin; A Rabe; R Dumas; A El Idrissi; H Haubenstock; W T Brown
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

7.  Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics.

Authors:  Claudia Bagni; Flora Tassone; Giovanni Neri; Randi Hagerman
Journal:  J Clin Invest       Date:  2012-12-03       Impact factor: 14.808

Review 8.  From FMRP function to potential therapies for fragile X syndrome.

Authors:  Ferzin Sethna; Changjong Moon; Hongbing Wang
Journal:  Neurochem Res       Date:  2013-12-18       Impact factor: 3.996

9.  Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice.

Authors:  Aditi Bhattacharya; Hanoch Kaphzan; Amanda C Alvarez-Dieppa; Jaclyn P Murphy; Philippe Pierre; Eric Klann
Journal:  Neuron       Date:  2012-10-17       Impact factor: 17.173

10.  FMRP targets distinct mRNA sequence elements to regulate protein expression.

Authors:  Manuel Ascano; Neelanjan Mukherjee; Pradeep Bandaru; Jason B Miller; Jeffrey D Nusbaum; David L Corcoran; Christine Langlois; Mathias Munschauer; Scott Dewell; Markus Hafner; Zev Williams; Uwe Ohler; Thomas Tuschl
Journal:  Nature       Date:  2012-12-12       Impact factor: 49.962

View more
  42 in total

1.  Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome.

Authors:  Mei Qin; Zachary Zeidler; Kristen Moulton; Leland Krych; Zengyan Xia; Carolyn B Smith
Journal:  Behav Brain Res       Date:  2015-05-12       Impact factor: 3.332

2.  Nanoparticle delivery of CRISPR into the brain rescues a mouse model of fragile X syndrome from exaggerated repetitive behaviours.

Authors:  Bumwhee Lee; Kunwoo Lee; Shree Panda; Rodrigo Gonzales-Rojas; Anthony Chong; Vladislav Bugay; Hyo Min Park; Robert Brenner; Niren Murthy; Hye Young Lee
Journal:  Nat Biomed Eng       Date:  2018-06-25       Impact factor: 25.671

3.  Genetic reduction of MMP-9 in the Fmr1 KO mouse partially rescues prepulse inhibition of acoustic startle response.

Authors:  Jamiela Kokash; Erin M Alderson; Sarah M Reinhard; Cynthia A Crawford; Devin K Binder; Iryna M Ethell; Khaleel A Razak
Journal:  Brain Res       Date:  2019-05-22       Impact factor: 3.252

Review 4.  Behavioral phenotypes of genetic mouse models of autism.

Authors:  T M Kazdoba; P T Leach; J N Crawley
Journal:  Genes Brain Behav       Date:  2015-10-22       Impact factor: 3.449

5.  Tonotopic alterations in inhibitory input to the medial nucleus of the trapezoid body in a mouse model of Fragile X syndrome.

Authors:  Elizabeth A McCullagh; Ernesto Salcedo; Molly M Huntsman; Achim Klug
Journal:  J Comp Neurol       Date:  2017-08-15       Impact factor: 3.215

6.  Increased Training Intensity Induces Proper Membrane Localization of Actin Remodeling Proteins in the Hippocampus Preventing Cognitive Deficits: Implications for Fragile X Syndrome.

Authors:  L A Martinez; Maria Victoria Tejada-Simon
Journal:  Mol Neurobiol       Date:  2017-07-08       Impact factor: 5.590

Review 7.  Modeling fragile X syndrome in the Fmr1 knockout mouse.

Authors:  Tatiana M Kazdoba; Prescott T Leach; Jill L Silverman; Jacqueline N Crawley
Journal:  Intractable Rare Dis Res       Date:  2014-11

Review 8.  The role of ARID1B, a BAF chromatin remodeling complex subunit, in neural development and behavior.

Authors:  Jeffrey J Moffat; Eui-Man Jung; Minhan Ka; Amanda L Smith; Byeong Tak Jeon; Gijs W E Santen; Woo-Yang Kim
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-08-24       Impact factor: 5.067

9.  Acute pharmacological inhibition of matrix metalloproteinase-9 activity during development restores perineuronal net formation and normalizes auditory processing in Fmr1 KO mice.

Authors:  Patricia S Pirbhoy; Maham Rais; Jonathan W Lovelace; Walker Woodard; Khaleel A Razak; Devin K Binder; Iryna M Ethell
Journal:  J Neurochem       Date:  2020-06-08       Impact factor: 5.372

10.  Audiogenic Seizures in the Fmr1 Knock-Out Mouse Are Induced by Fmr1 Deletion in Subcortical, VGlut2-Expressing Excitatory Neurons and Require Deletion in the Inferior Colliculus.

Authors:  Darya Gonzalez; Madison Tomasek; Seth Hays; Vinay Sridhar; Simon Ammanuel; Chia-Wei Chang; Karen Pawlowski; Kimberly M Huber; Jay R Gibson
Journal:  J Neurosci       Date:  2019-10-30       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.